 |
High Potential Start-UpsThe Interview Series Author: Nick Taylor
Well learn from life science leaders about the groundbreaking work theyre involved with, and the journey theyve taken to get to where they are in their career today - what motivates them, how they made it to the C suite in the first place, what it takes to stay there, and where they plan to go next. Guests are positioned as expert minds on compelling missions. The chance to align with personalities and brands on a similar journey is a major draw for talent in todays busy marketplace. An appearance on the podcast serves as a priceless piece of branding collateral that employers can guarantee represents their message faithfully. Moreover, the podcast affords our guests a platform to draw international attention to the work their organisation is doing, introducing their brand to a global audience of potential investors in the process. Language: en Genres: Business, Entrepreneurship, Investing Contact email: Get it Feed URL: Get it iTunes ID: Get it |
Listen Now...
Emil Pot, Co-Founder and CEO of Allero Therapeutics
Episode 3
Wednesday, 20 October, 2021
As something that affects as much as 10% of the global population, food allergies are an important topic of discussion in this value-packed episode of High Potential Start-ups.In episode 3, guest speaker Emil Pot, Co-Founder and CEO of Allero Therapeutics, and host Nick Ross, Co-Founder of Cavenagh Health, delve into numerous talking points surrounding everything from food-related immune disorders to running a successful biotech company. Emil’s career started in law, but his keen interest in science quickly led to biotech becoming the central point of his career.Now, Emil and his team at Allero Therapeutics have developed an innovative solution to treating autoimmune disorders like celiac disease.Get in touch with Emil.Get in Touch with Nick.
